Does anybody have details about the trial? (how is it designed, what phase, the main goal, age of participants, type of MS, inclusion and exclusion criteria, primary and secondary outcomes, etc...)
Thanks in advance!
http://www.peptimmune.com/research_deve ... is/pi_2301
Also, Squiffy had posted this:
http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1397
Actually, if you want to get more information about their upcoming trials, maybe the best thing to do is call the company.